Background

• The use of antiseizure medications (ASMs) in pregnancy has increased. Up to 2% of all children are now born to women exposed to ASMs during pregnancy.
• Studies implicate valproate prenatal exposure in congenital anomalies and adverse neurodevelopment, but wider study of prenatal ASM in relation to a broad range ...